Hengrui Pharma

600276

53.891.13% ( +0.60 )

Delay Closed: Jul 29, 15:00:00

Q1 2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Hengrui Pharma(600276) predict that the Revenue is 8.141 B (+12.98%), Miss estimate;the EBIT is 2.607 B (+25%), Beat estimate;the EPS is 0.34 (+13.33%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

8.14B12.98%

8.28B14.87%

-0.14B1.89%

EBITExceed expectations

2.61B25.00%

2.24B7.31%

+0.37B17.69%

EPSExceed expectations

0.3413.33%

0.330610.19%

+0.00943.14%

Upcoming earnings report - FY2026 Semi-Annual Earning Release

Available dateAug 19, 2026

Estimate Revenue16.77 B

Estimate EBIT5.216 B

Estimate EPS--

Revenue

ActualEstimateUnit: CNY

EBIT

ActualEstimateUnit: CNY

Net income

ActualEstimateUnit: CNY

EPS

ActualEstimateUnit: CNY